Mice Model Market by Mice Type (Inbred, Knockout), Technology (CRISPR, TALEN, ZFN), Application (Oncology, Diabetes, Immunology), Service (Breeding, Cryopreservation, Genetic testing), Care Products (Cages, Bedding, Feed), Region - Global Forecast to 2025

マウスモデルの世界市場予測(〜2025):種類別(近交系、ノックアウト)、技術別(CRISPR、TALEN、ZFN)、用途別(腫瘍学、糖尿病、免疫学)、サービス別(育種、凍結保存、遺伝子検査)、ケア製品別(ケージ、寝具、飼料)、地域別

◆タイトル:Mice Model Market by Mice Type (Inbred, Knockout), Technology (CRISPR, TALEN, ZFN), Application (Oncology, Diabetes, Immunology), Service (Breeding, Cryopreservation, Genetic testing), Care Products (Cages, Bedding, Feed), Region - Global Forecast to 2025
◆商品コード:BT 2192
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年9月16日
◆ページ数:253
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオテクノロジー
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥698,250見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥855,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

Marketsandmarkets社はマウスモデルの世界市場が2020年14億ドルから2025年19億ドルまで、年平均6.4%成長すると予測しています。本調査レポートでは、マウスモデルの世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、規制評価、臨床試験評価、マウス種類別(近親交配マウス、アウトブレッドマウス、遺伝子改変マウス、ハイブリッド/先天性マウス、条件付き/外科的改変マウス)分析、サービス別(育種、凍結保存、検疫、派生、モデルライセンス供与)分析、技術別(CRISPR/CAS9、マイクロインジェクション、胚性幹細胞注射、核移植、その他)分析、用途別(腫瘍学研究、免疫学・炎症研究、内分泌代謝研究、心血管研究、中枢神経系(CNS)研究)分析、マウスケア製品別(ケージ、飼料、寝具)分析、地域別分析、競争状況、企業評価・情報などをまとめております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・規制評価
・臨床試験評価
・マウスモデルの世界市場規模:マウス種類別(近親交配マウス、アウトブレッドマウス、遺伝子改変マウス、ハイブリッド/先天性マウス、条件付き/外科的改変マウス)
・マウスモデルの世界市場規模:サービス別(育種、凍結保存、検疫、派生、モデルライセンス供与)
・マウスモデルの世界市場規模:技術別(CRISPR/CAS9、マイクロインジェクション、胚性幹細胞注射、核移植、その他)
・マウスモデルの世界市場規模:用途別(腫瘍学研究、免疫学・炎症研究、内分泌代謝研究、心血管研究、中枢神経系(CNS)研究)
・マウスモデルの世界市場規模:マウスケア製品別(ケージ、飼料、寝具)
・マウスモデルの世界市場規模:地域別
・競争状況
・企業評価・情報

“Increasing implication of mouse clinical trials (MCTs) and ongoing innovation in mice models are set to drive the mice model market.”
The global mice model market size is projected to reach USD 1.9 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.4% during the forecast period. The major factors driving the growth of this market are the Growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increasing implications of mouse clinical trials (MCTs) for more predictive outcomes and ongoing innovations in mice models are driving the growth of the global mice model industry. However, Implementation of laws and regulations for animal protection and welfare has enforced restrictive practices and bans on the use of animals for different purposes that may restrict the growth of this market to a certain extent.

“By mice type, the genetically engineered mice accounted for the fastest-growing segment of the mice model market.”
Genetically engineered mice segment is anticipated to be the fastest-growing due to the widespread use of these mice in diverse research areas, the emerging CRISPR technology, increasing focus on personalized medicine with the continuous introduction of new models

“By service, the breeding segment accounted for the largest share of the mice model market.”
The breeding segment is expected to account for the largest market share in 2020, with the highest growth rate as well. This can primarily be attributed to the increasing demand for mice models for drug discovery and development and the subsequent increase in the demand for personalized medicines.

“Oncology segment expected to grow at the fastest growth rate during the forecast period.”
Based on application, the mice model market has been segmented into oncology studies, immunology and inflammation studies, endocrine metabolic studies, cardiovascular studies, central nervous system studies (CNS), genetic studies, infectious disease studies, and other disease studies. The endocrine disease studies segment is further segmented into diabetes and other endocrine metabolic disease. The oncology segment is expected to account for the largest market share in 2020, with the highest growth rate as well. This can primarily be attributed to the increasing number of patients who have cancer and the subsequent increase in the demand for cancer therapies.

“By technology type, CRISPR/Cas9 accounted for the largest share of the mice model market”
CRISPR is the most widely used technology in the mice model market and contributed to the largest share of the mice model market in 2020. Ease of design, high efficiency, and relatively lower cost have increased the demand for CRISPR-customized mice models.

“By mice care product, cages segment accounted for the largest share of the mice model market”
Based on mice care products, the mice model market has been segmented into cages, feed, bedding, and other products (gnotobiotic equipment, water systems, and accessories). The cages segment accounted for the largest share of the mice model market. This can be attributed to the availability of a wide range of cages designed for specific research needs and the higher cost of cages compared to other care products.

“Asia Pacific: The fastest-growing region in the mice model market.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Several global pharmaceutical firms have entered the APAC market to tap the significant growth opportunities in emerging Asian countries and lower their production costs by shifting their drug discovery R&D operations and manufacturing to the region. A large number of qualified researchers and low-cost operations in APAC countries, such as India and China, are some of the major factors supporting this trend.

“North America: The largest share of the drug discovery services market.”
North America, which includes the US and Canada, accounted for the largest share of the mice model market. The large share of the North America region can be attributed to the presence of major players operating in the mice model market in the US, growing biomedical research in the US, and rising preclinical activities by CROs and pharmaceutical companies in the region.
Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

• By Respondent– Supply Side- 80%, Demand Side-20%
• By Designation— Executives- 25%, CXOs- 20%, Managers – 55%
• By Region— North America – 50%, Europe – 20%, APAC – 20%, RoW- 10%

The mice model market is dominated by a few globally established players such as Charles River Laboratories (US) The Jackson Laboratory (US), Taconic Biosciences, Inc. (US), Envigo (US), JANVIER LABS (France), genOway (France), PolyGene (Switzerland), Crown Biosciences (US), TransCure Bioservices (France), Ingenious Targeting Laboratory (US), Cyagen Biosciences (US), GVK BIO (India), The Andersons, Inc. (US), Innovive (US), Allentown, LLC (US), FENGSHI GROUP (China), Ozgene Pty Ltd. (Australia), and Harbour Biomed (US).

Research Coverage:
The report segments the mice model market based on region (North America, Asia Pacific, Europe, and RoW), mice type (inbred mice, outbred mice, conditioned/surgically modified mice, hybrid/congenic mice, genetically engineered mice, and spontaneous mutant mice), service (breeding, quarantine, cryopreservation, rederivation, genetic testing, model in-licensing, and other services ((surgical, line rescue, and in vivo pharmacology services)), application (oncology studies, immunology and inflammation studies, endocrine metabolic studies, cardiovascular studies, central nervous system studies (CNS), genetic studies, infectious disease studies, and other disease studies), technology (CRISPR/Cas9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies (virus/vector-mediated gene transfer, and TALENs & ZFNs)) and mice care product (cages, feed, bedding and other products (gnotobiotic equipment, water systems, and accessories)), Company type (Tier 1, tier 2, Tier3 mice providers). The report also provides a comprehensive review of market drivers, challenges, and opportunities in the mice model market.

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the mice model market and provides them information on key market drivers, challenges, and opportunities.

【レポートの目次】

1 INTRODUCTION 40
1.1 OBJECTIVES OF THE STUDY 40
1.2 MARKET DEFINITION 41
1.2.1 INCLUSIONS & EXCLUSIONS 41
1.3 MARKET SCOPE 42
1.3.1 MARKETS COVERED 42
1.3.2 YEARS CONSIDERED FOR THE STUDY 43
1.4 CURRENCY 43
1.5 LIMITATIONS 43
1.6 STAKEHOLDERS 44
1.7 SUMMARY OF CHANGES 44
2 RESEARCH METHODOLOGY 45
2.1 RESEARCH DATA 45
2.1.1 SECONDARY DATA 45
2.1.2 PRIMARY DATA 46
FIGURE 1 BREAKDOWN OF PRIMARIES: MICE MODEL MARKET 46
2.1.3 MARKET DATA ESTIMATION & TRIANGULATION 47
2.1.3.1 Data triangulation 47
FIGURE 2 DATA TRIANGULATION METHODOLOGY 47
2.2 MARKET ESTIMATION METHODOLOGY 48
FIGURE 3 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION) 48
FIGURE 4 MICE MODEL MARKET SIZE (USD MILLION) 48
FIGURE 5 MICE MODEL MARKET: GROWTH RATE OF TOP COMPANIES (2018−2019) 49
FIGURE 6 MICE MODEL MARKET: FINAL CAGR PROJECTIONS (2020−2025) 49
FIGURE 7 MICE MODEL MARKET: CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES 50
2.3 INDUSTRY INSIGHTS 51
2.4 RESEARCH ASSUMPTIONS 51
3 EXECUTIVE SUMMARY 52
FIGURE 8 MICE MODEL MARKET SHARE, BY MICE TYPE, 2019 52
FIGURE 9 MICE MODEL MARKET SHARE, BY SERVICE, 2019 53
FIGURE 10 MICE MODEL MARKET, BY APPLICATION: MARKET RANKING OF SEGMENTS, BY MARKET SIZE 54
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE MICE MODEL MARKET 55

4 PREMIUM INSIGHTS 56
4.1 MICE MODEL MARKET OVERVIEW 56
FIGURE 12 GROWTH IN NUMBER OF PHARMACEUTICAL R&D ACTIVITIES AND GROWING DEMAND FOR PERSONALIZED MEDICINE WILL FAVOR MARKET GROWTH 56
4.2 ASIA PACIFIC: MICE MODEL MARKET SHARE, BY MICE CARE PRODUCT AND
BY COUNTRY (2019) 57
FIGURE 13 THE CAGES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF
THE ASIA PACIFIC MARKET IN 2019 57
4.3 MICE MODEL MARKET, BY MICE TYPE 58
FIGURE 14 INBRED MICE SEGMENT WILL CONTINUE TO DOMINATE THE MARKET 58
4.4 MICE MODEL MARKET SHARE, BY SERVICE, 2020 VS. 2025 58
FIGURE 15 IN TERMS OF SERVICE, BREEDING HOLDS THE LARGEST SHARE OF
THE MARKET 58
4.5 MICE MODEL MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION) 59
FIGURE 16 ONCOLOGY STUDIES SEGMENT ACCOUNTS FOR THE LARGEST MARKET SHARE 59
5 MARKET OVERVIEW 60
5.1 INTRODUCTION 60
5.2 MARKET DYNAMICS 60
FIGURE 17 MICE MODEL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 60
5.2.1 MARKET DRIVERS 61
5.2.1.1 Growing usage of mice models in virology and infectious diseases 61
5.2.1.2 Increasing implications of mouse clinical trials (MCTs) for more predictive outcomes 61
5.2.1.3 Increasing demand for personalized medicine 62
5.2.2 RESTRAINTS 62
5.2.2.1 Regulations and laws for the ethical use of animals in research 62
5.2.3 OPPORTUNITIES 63
5.2.3.1 CRISPR emerging as a powerful tool in biomedical research 63
5.2.3.2 Rising demand for humanized mice models 63
5.2.4 CHALLENGES 63
5.2.4.1 Development of alternative animal testing methods 63
5.2.5 THREATS 64
5.2.5.1 Growing use of rat models 64
5.3 IMPACT OF THE COVID-19 OUTBREAK ON THE GROWTH OF THE MICE MODEL MARKET 64
6 REGULATORY ASSESSMENT 65
6.1 INTRODUCTION 65
6.2 NORTH AMERICA 65
6.3 EUROPE 66
6.4 CHINA 67
6.5 JAPAN 68
6.6 INDIA 68
6.7 AUSTRALIA 69
6.8 BRAZIL 69
7 CLINICAL STUDIES ASSESSMENT 70
7.1 INTRODUCTION 70
7.2 CLINICAL STUDIES 70
FIGURE 18 CLINICAL STUDIES USING MICE MODELS, BY INDICATION (2017 ONWARDS) 70
FIGURE 19 CLINICAL STUDIES USING MICE MODELS, BY COMPLETION
(2017 ONWARDS) 71
TABLE 1 INDICATIVE LIST OF CLINICAL STUDIES CONDUCTED USING MICE MODELS 71
8 MICE MODEL MARKET, BY MICE TYPE 72
8.1 INTRODUCTION 73
TABLE 2 MICE MODEL MARKET, BY MICE TYPE, 2018–2025 (USD MILLION) 73
8.2 INBRED MICE 73
8.2.1 INCREASING APPLICATIONS OF INBRED MICE LIKELY TO DRIVE THE MARKET 73
TABLE 3 INBRED MICE MODEL MARKET, BY REGION, 2018–2025 (USD MILLION) 74
TABLE 4 NORTH AMERICA: INBRED MICE MODEL MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 74
TABLE 5 EUROPE: INBRED MICE MODEL MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 74
TABLE 6 ASIA PACIFIC: INBRED MICE MODEL MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 75
TABLE 7 ROW: INBRED MICE MODEL MARKET, BY REGION,
2018–2025 (USD MILLION) 75
8.3 OUTBRED MICE 75
8.3.1 GENETIC DIVERSITY OFFERED BY OUTBRED MICE TO BOOST THE MARKET 75
TABLE 8 OUTBRED MICE MODEL MARKET, BY REGION, 2018–2025 (USD MILLION) 76
TABLE 9 NORTH AMERICA: OUTBRED MICE MODEL MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 76
TABLE 10 EUROPE: OUTBRED MICE MODEL MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 76
TABLE 11 ASIA PACIFIC: OUTBRED MICE MODEL MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 77
TABLE 12 ROW: OUTBRED MICE MODEL MARKET, BY REGION,
2018–2025 (USD MILLION) 77
8.4 GENETICALLY ENGINEERED MICE 77
8.4.1 INCREASING FOCUS ON PERSONALIZED MEDICINES TO DRIVE DEMAND 77
TABLE 13 GENETICALLY ENGINEERED MICE MODEL MARKET, BY REGION,
2018–2025 (USD MILLION) 78
TABLE 14 NORTH AMERICA: GENETICALLY ENGINEERED MICE MODEL MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 78
TABLE 15 EUROPE: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 78
TABLE 16 ASIA PACIFIC: GENETICALLY ENGINEERED MICE MODEL MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 79
TABLE 17 ROW: GENETICALLY ENGINEERED MICE MODEL MARKET, BY REGION,
2018–2025 (USD MILLION) 79
8.5 HYBRID/CONGENIC MICE 79
8.5.1 INCREASING USE OF CONGENIC MICE IN BIOMEDICAL RESEARCH CONTRIBUTES TO MARKET GROWTH 79
TABLE 18 HYBRID/CONGENIC MICE MODEL MARKET, BY REGION,
2018–2025 (USD MILLION) 80
TABLE 19 NORTH AMERICA: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 80
TABLE 20 EUROPE: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 80
TABLE 21 ASIA PACIFIC: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 81
TABLE 22 ROW: HYBRID/CONGENIC MICE MODEL MARKET, BY REGION,
2018–2025 (USD MILLION) 81
8.6 CONDITIONED/SURGICALLY MODIFIED MICE 81
8.6.1 INCREASING INCIDENCE OF METABOLIC DISEASES TO DRIVE THE MARKET 81
TABLE 23 CONDITIONED/SURGICALLY MODIFIED MICE MODEL MARKET, BY REGION, 2018–2025 (USD MILLION) 82
TABLE 24 NORTH AMERICA: CONDITIONED/SURGICALLY MODIFIED MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 82
TABLE 25 EUROPE: CONDITIONED/SURGICALLY MODIFIED MICE MODEL MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 82
TABLE 26 ASIA PACIFIC: CONDITIONED/SURGICALLY MODIFIED MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 83
TABLE 27 ROW: CONDITIONED/SURGICALLY MODIFIED MICE MODEL MARKET,
BY REGION, 2018–2025 (USD MILLION) 83
8.7 SPONTANEOUS MUTANT MICE 83
8.7.1 ADVANCEMENTS IN BIOMEDICAL RESEARCH AND INCREASING APPLICATIONS TO BOOST DEMAND 83
TABLE 28 SPONTANEOUS MUTANT MICE MODEL MARKET, BY REGION,
2018–2025 (USD MILLION) 84
TABLE 29 NORTH AMERICA: SPONTANEOUS MUTANT MICE MODEL MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 84
TABLE 30 EUROPE: SPONTANEOUS MUTANT MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 84
TABLE 31 ASIA PACIFIC: SPONTANEOUS MUTANT MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 85
TABLE 32 ROW: SPONTANEOUS MUTANT MICE MODEL MARKET, BY REGION,
2018–2025 (USD MILLION) 85
9 MICE MODEL MARKET, BY SERVICE 86
9.1 INTRODUCTION 87
TABLE 33 MICE MODEL MARKET, BY SERVICE, 2018–2025 (USD MILLION) 87
9.2 BREEDING 87
9.2.1 GROWING NUMBER OF MICE MODEL STUDIES TO BOOST THE MARKET 87
TABLE 34 BREEDING SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 88
TABLE 35 NORTH AMERICA: BREEDING SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 88
TABLE 36 EUROPE: BREEDING SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 88
TABLE 37 ASIA PACIFIC: BREEDING SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 89
TABLE 38 ROW: BREEDING SERVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 89
9.3 CRYOPRESERVATION 89
9.3.1 NEED FOR PRESERVATION OF NOVEL MICE MODELS LIKELY TO DRIVE
THE MARKET 89
TABLE 39 CRYOPRESERVATION SERVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 90
TABLE 40 NORTH AMERICA: CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 90
TABLE 41 EUROPE: CRYOPRESERVATION SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 90
TABLE 42 ASIA PACIFIC: CRYOPRESERVATION SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 91
TABLE 43 ROW: CRYOPRESERVATION SERVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 91
9.4 QUARANTINE 91
9.4.1 RISING DEMAND FOR GERM-FREE MICE TO BOOST MARKET 91
TABLE 44 QUARANTINE SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 92
TABLE 45 NORTH AMERICA: QUARANTINE SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 92
TABLE 46 EUROPE: QUARANTINE SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 92
TABLE 47 ASIA PACIFIC: QUARANTINE SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 93
TABLE 48 ROW: QUARANTINE SERVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 93
9.5 REDERIVATION 93
9.5.1 STRINGENT QUALITY ASSURANCE STANDARDS TO BOOST THE MARKET 93
TABLE 49 REDERIVATION SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 94
TABLE 50 NORTH AMERICA: REDERIVATION SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 94
TABLE 51 EUROPE: REDERIVATION SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 94
TABLE 52 ASIA PACIFIC: REDERIVATION SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 95
TABLE 53 ROW: REDERIVATION SERVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 95
9.6 MODEL IN-LICENSING 95
9.6.1 INCREASING INDEPENDENT RESEARCH BY SCIENTIFIC COMMUNITY LIKELY TO FUEL MARKET GROWTH 95
TABLE 54 MODEL IN-LICENSING SERVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 96
TABLE 55 NORTH AMERICA: MODEL IN-LICENSING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 96
TABLE 56 EUROPE: MODEL IN-LICENSING SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 96
TABLE 57 ASIA PACIFIC: MODEL IN-LICENSING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 97
TABLE 58 ROW: MODEL IN-LICENSING SERVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 97
9.7 GENETIC TESTING 97
9.7.1 RISING DEMAND FOR TRANSGENIC MICE LIKELY TO DRIVE THE MARKET 97
TABLE 59 GENETIC TESTING SERVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 98
TABLE 60 NORTH AMERICA: GENETIC TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 98
TABLE 61 EUROPE: GENETIC TESTING SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 98
TABLE 62 ASIA PACIFIC: GENETIC TESTING SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 99
TABLE 63 ROW: GENETIC TESTING SERVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 99
9.8 OTHER SERVICES 99
TABLE 64 OTHER SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 100
TABLE 65 NORTH AMERICA: OTHER SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 100
TABLE 66 EUROPE: OTHER SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 100
TABLE 67 ASIA PACIFIC: OTHER SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 101
TABLE 68 ROW: OTHER SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 101
10 MICE MODEL MARKET, BY TECHNOLOGY 102
10.1 INTRODUCTION 103
TABLE 69 MICE MODEL MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 103
TABLE 70 MICE MODEL MARKET, BY OTHER TECHNOLOGIES,
2018–2025 (USD MILLION) 103
10.2 CRISPR/CAS9 104
10.2.1 ADVANTAGES OF CRISPR LIKELY TO BOOST SEGMENT GROWTH 104
TABLE 71 MICE MODEL MARKET SIZE FOR CRISPR TECHNOLOGY, BY REGION,
2018–2025 (USD MILLION) 104
TABLE 72 NORTH AMERICA: CRISPR TECHNOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 104
TABLE 73 EUROPE: CRISPR TECHNOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 105
TABLE 74 ASIA PACIFIC: CRISPR TECHNOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 105
TABLE 75 ROW: CRISPR TECHNOLOGY MARKET, BY REGION,
2018–2025 (USD MILLION) 105
10.3 MICROINJECTION 106
10.3.1 HIGH SUCCESS RATE AND LACK OF CONSTRAINTS TO PROPEL SEGMENT 106
TABLE 76 MICE MODEL MARKET SIZE FOR MICROINJECTION TECHNOLOGY, BY REGION, 2018–2025 (USD MILLION) 106
TABLE 77 NORTH AMERICA: MICROINJECTION TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 106
TABLE 78 EUROPE: MICROINJECTION TECHNOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 107
TABLE 79 ASIA PACIFIC: MICROINJECTION TECHNOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 107
TABLE 80 ROW: MICROINJECTION TECHNOLOGY MARKET, BY REGION,
2018–2025 (USD MILLION) 107
10.4 EMBRYONIC STEM CELL INJECTION 108
10.4.1 GROWING DEMAND FOR TARGETED MICE MODELS TO PROPEL THE MARKET 108
TABLE 81 MICE MODEL MARKET SIZE FOR EMBRYONIC STEM CELL INJECTION TECHNOLOGY, BY REGION, 2018–2025 (USD MILLION) 108
TABLE 82 NORTH AMERICA: EMBRYONIC STEM CELL INJECTION TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 108
TABLE 83 EUROPE: EMBRYONIC STEM CELL INJECTION TECHNOLOGY MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 109
TABLE 84 ASIA PACIFIC: EMBRYONIC STEM CELL INJECTION TECHNOLOGY MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 109
TABLE 85 ROW: EMBRYONIC STEM CELL INJECTION TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION) 109
10.5 NUCLEAR TRANSFER 110
10.5.1 POTENTIAL TO PRODUCE IDENTICAL MICE IS LIKELY TO DRIVE MARKET GROWTH 110
TABLE 86 MICE MODEL MARKET SIZE FOR NUCLEAR TRANSFER TECHNOLOGY,
BY REGION, 2018–2025 (USD MILLION) 110
TABLE 87 NORTH AMERICA: NUCLEAR TRANSFER TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 110
TABLE 88 EUROPE: NUCLEAR TRANSFER TECHNOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 111
TABLE 89 ASIA PACIFIC: NUCLEAR TRANSFER TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 111
TABLE 90 ROW: NUCLEAR TRANSFER TECHNOLOGY MARKET, BY REGION,
2018–2025 (USD MILLION) 111
10.6 OTHER TECHNOLOGIES 112
TABLE 91 MICE MODEL MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION,
2018–2025 (USD MILLION) 112
TABLE 92 NORTH AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 112
TABLE 93 EUROPE: OTHER TECHNOLOGIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 113
TABLE 94 ASIA PACIFIC: OTHER TECHNOLOGIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 113
TABLE 95 ROW: OTHER TECHNOLOGIES MARKET, BY REGION,
2018–2025 (USD MILLION) 113
10.6.1 SPERM-MEDIATED GENE TRANSFER 114
TABLE 96 MICE MODEL MARKET SIZE FOR SPERM-MEDIATED GENE TRANSFER TECHNOLOGY, BY REGION, 2018–2025 (USD MILLION) 114
10.6.2 VIRUS/VECTOR-MEDIATED GENE TRANSFER 114
TABLE 97 MICE MODEL MARKET SIZE FOR VIRUS/VECTOR-MEDIATED GENE TRANSFER TECHNOLOGY, BY REGION, 2018–2025 (USD MILLION) 115
10.6.3 LIPOSOME-MEDIATED DNA AND ELECTROPORATION OF DNA 115
TABLE 98 MICE MODEL MARKET SIZE FOR LIPOSOME-MEDIATED DNA AND ELECTROPORATION OF DNA TECHNOLOGY, BY REGION,
2018–2025 (USD MILLION) 115
10.6.4 BIOLISTICS 116
TABLE 99 MICE MODEL MARKET SIZE FOR BIOLISTICS TECHNOLOGY, BY REGION, 2018–2025 (USD MILLION) 116
10.6.5 TALENS AND ZFNS 116
TABLE 100 MICE MODEL MARKET SIZE FOR TALENS AND ZFNS TECHNOLOGY,
BY REGION, 2018–2025 (USD MILLION) 116
11 MICE MODEL MARKET, BY APPLICATION 117
11.1 INTRODUCTION 118
TABLE 101 MICE MODEL MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 118
TABLE 102 MICE MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES,
2018–2025 (USD MILLION) 118
11.2 ONCOLOGY STUDIES 119
11.2.1 INCREASING IMPLICATIONS OF MICE MODELS IN STUDY OF CANCER TO DRIVE THE MARKET 119
TABLE 103 MICE MODEL MARKET SIZE FOR ONCOLOGY STUDIES, BY REGION,
2018–2025 (USD MILLION) 119
TABLE 104 NORTH AMERICA: ONCOLOGY STUDIES MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 119
TABLE 105 EUROPE: ONCOLOGY STUDIES MICE MODEL MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 120
TABLE 106 ASIA PACIFIC: ONCOLOGY STUDIES MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 120
TABLE 107 ROW: ONCOLOGY STUDIES MICE MODEL MARKET, BY REGION,
2018–2025 (USD MILLION) 120
11.3 IMMUNOLOGY AND INFLAMMATION STUDIES 121
11.3.1 DEVELOPMENT OF ADVANCED MODELS FOR HUMAN IMMUNOLOGY STUDIES TO BOOST MARKET GROWTH 121
TABLE 108 MICE MODEL MARKET SIZE FOR IMMUNOLOGY AND INFLAMMATION STUDIES, BY REGION, 2018–2025 (USD MILLION) 121
TABLE 109 NORTH AMERICA: IMMUNOLOGY AND INFLAMMATION STUDIES MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 121
TABLE 110 EUROPE: IMMUNOLOGY AND INFLAMMATION STUDIES MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 122
TABLE 111 ASIA PACIFIC: IMMUNOLOGY AND INFLAMMATION STUDIES MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 122
TABLE 112 ROW: IMMUNOLOGY AND INFLAMMATION STUDIES MICE MODEL MARKET, BY REGION, 2018–2025 (USD MILLION) 122
11.4 ENDOCRINE METABOLIC STUDIES 123
11.4.1 GROWING PREVALENCE OF METABOLIC DISORDERS LIKELY TO DRIVE THE MARKET 123
TABLE 113 MICE MODEL MARKET SIZE FOR ENDOCRINE METABOLIC STUDIES,
BY REGION, 2018–2025 (USD MILLION) 123
TABLE 114 NORTH AMERICA: ENDOCRINE METABOLIC STUDIES MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 123
TABLE 115 EUROPE: ENDOCRINE METABOLIC STUDIES MICE MODEL MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 124
TABLE 116 ASIA PACIFIC: ENDOCRINE METABOLIC STUDIES MICE MODEL MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 124
TABLE 117 ROW: ENDOCRINE METABOLIC STUDIES MICE MODEL MARKET, BY REGION, 2018–2025 (USD MILLION) 124
11.4.2 DIABETES STUDIES 125
TABLE 118 MICE MODEL MARKET SIZE FOR DIABETES STUDIES, BY REGION,
2018–2025 (USD MILLION) 125
TABLE 119 NORTH AMERICA: DIABETES STUDIES MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 125
TABLE 120 EUROPE: DIABETES STUDIES MICE MODEL MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 126
TABLE 121 ASIA PACIFIC: DIABETES STUDIES MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 126
TABLE 122 ROW: DIABETES STUDIES MICE MODEL MARKET, BY REGION,
2018–2025 (USD MILLION) 126
11.4.3 OTHER ENDOCRINE METABOLIC STUDIES 127
TABLE 123 MICE MODEL MARKET SIZE FOR OTHER ENDOCRINE METABOLIC STUDIES,
BY REGION, 2018–2025 (USD MILLION) 127
11.5 CARDIOVASCULAR STUDIES 127
11.5.1 RISING BURDEN OF CARDIOVASCULAR DISORDERS HAS BOOSTED OVERALL R&D ACTIVITY 127
TABLE 124 MICE MODEL MARKET SIZE FOR CARDIOVASCULAR STUDIES, BY REGION, 2018–2025 (USD MILLION) 128
TABLE 125 NORTH AMERICA: CARDIOVASCULAR STUDIES MICE MODEL MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 128
TABLE 126 EUROPE: CARDIOVASCULAR STUDIES MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 128
TABLE 127 ASIA PACIFIC: CARDIOVASCULAR STUDIES MICE MODEL MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 129
TABLE 128 ROW: CARDIOVASCULAR STUDIES MICE MODEL MARKET, BY REGION,
2018–2025 (USD MILLION) 129
11.6 CENTRAL NERVOUS SYSTEM (CNS) STUDIES 129
11.6.1 INCREASING FOCUS ON MICE MODEL DEVELOPMENT FOR CNS DISORDERS TO PROPEL MARKET 129
TABLE 129 MICE MODEL MARKET SIZE FOR CENTRAL NERVOUS SYSTEM STUDIES,
BY REGION, 2018–2025 (USD MILLION) 130
TABLE 130 NORTH AMERICA: CENTRAL NERVOUS SYSTEM STUDIES MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 130
TABLE 131 EUROPE: CENTRAL NERVOUS SYSTEM STUDIES MICE MODEL MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 130
TABLE 132 ASIA PACIFIC: CENTRAL NERVOUS SYSTEM STUDIES MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 131
TABLE 133 ROW: CENTRAL NERVOUS SYSTEM STUDIES MICE MODEL MARKET,
BY REGION, 2018–2025 (USD MILLION) 131
11.7 GENETIC STUDIES 131
11.7.1 ADVANCEMENTS IN GENE EDITING TECHNIQUES TO DRIVE THE MARKET 131
TABLE 134 MICE MODEL MARKET SIZE FOR GENETIC STUDIES, BY REGION,
2018–2025 (USD MILLION) 132
TABLE 135 NORTH AMERICA: GENETIC STUDIES MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 132
TABLE 136 EUROPE: GENETIC STUDIES MICE MODEL MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 132
TABLE 137 ASIA PACIFIC: GENETIC STUDIES MICE MODEL MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 133
TABLE 138 ROW: GENETIC STUDIES MICE MODEL MARKET, BY REGION,
2018–2025 (USD MILLION) 133
11.8 INFECTIOUS DISEASE STUDIES 133
11.8.1 INCREASING OUTBREAKS OF INFECTIOUS DISEASES TO PROPEL DRUG DEVELOPMENT ACTIVITIES 133
TABLE 139 MICE MODEL MARKET SIZE FOR INFECTIOUS DISEASE STUDIES, BY REGION, 2018–2025 (USD MILLION) 134
TABLE 140 NORTH AMERICA: INFECTIOUS DISEASE STUDIES MICE MODEL MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 134
TABLE 141 EUROPE: INFECTIOUS DISEASE STUDIES MICE MODEL MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 134
TABLE 142 ASIA PACIFIC: INFECTIOUS DISEASE STUDIES MICE MODEL MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 135
TABLE 143 ROW: INFECTIOUS DISEASE STUDIES MICE MODEL MARKET, BY REGION, 2018–2025 (USD MILLION) 135
11.9 OTHER DISEASE STUDIES 136
TABLE 144 MICE MODEL MARKET SIZE FOR OTHER DISEASE STUDIES, BY REGION, 2018–2025 (USD MILLION) 136
TABLE 145 NORTH AMERICA: OTHER DISEASE STUDIES MICE MODEL MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 136
TABLE 146 EUROPE: OTHER DISEASE STUDIES MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 137
TABLE 147 ASIA PACIFIC: OTHER DISEASE STUDIES MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 137
TABLE 148 ROW: OTHER DISEASE STUDIES MICE MODEL MARKET, BY REGION,
2018–2025 (USD MILLION) 137
12 MICE MODEL MARKET, BY MICE CARE PRODUCT 138
12.1 INTRODUCTION 139
TABLE 149 MICE CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 139
12.2 CAGES 139
12.2.1 DEVELOPMENT OF DIFFERENT CAGE SYSTEMS TO DRIVE THE MARKET 139
TABLE 150 MICE CAGES MARKET, BY REGION, 2018–2025 (USD MILLION) 140
TABLE 151 NORTH AMERICA: MICE CAGES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 140
TABLE 152 EUROPE: MICE CAGES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 140
TABLE 153 ASIA PACIFIC: MICE CAGES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 141
TABLE 154 ROW: MICE CAGES MARKET, BY REGION, 2018–2025 (USD MILLION) 141
12.3 FEED 141
12.3.1 PREFERENCE FOR HEALTHY AND POWERED DIET TO DRIVE THE MARKET 141
TABLE 155 MICE FEED MARKET, BY REGION, 2018–2025 (USD MILLION) 142
TABLE 156 NORTH AMERICA: MICE FEED MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 142
TABLE 157 EUROPE: MICE FEED MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 142
TABLE 158 ASIA PACIFIC: MICE FEED MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 143
TABLE 159 ROW: MICE FEED MARKET, BY REGION, 2018–2025 (USD MILLION) 143
12.4 BEDDING 143
12.4.1 ENVIRONMENTAL ENRICHMENT STRATEGY FOR WELFARE OF LABORATORY ANIMALS LIKELY TO BOOST MARKET GROWTH 143
TABLE 160 MICE BEDDING MARKET, BY REGION, 2018–2025 (USD MILLION) 144
TABLE 161 NORTH AMERICA: MICE BEDDING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 144
TABLE 162 EUROPE: MICE BEDDING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 144
TABLE 163 ASIA PACIFIC: MICE BEDDING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 145
TABLE 164 ROW: MICE BEDDING MARKET, BY REGION, 2018–2025 (USD MILLION) 145
12.5 OTHER MICE CARE PRODUCTS 145
TABLE 165 OTHER MICE CARE PRODUCTS MARKET, BY REGION,
2018–2025 (USD MILLION) 146
TABLE 166 NORTH AMERICA: OTHER MICE CARE PRODUCTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 146
TABLE 167 EUROPE: OTHER MICE CARE PRODUCTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 146
TABLE 168 ASIA PACIFIC: OTHER MICE CARE PRODUCTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 147
TABLE 169 ROW: OTHER MICE CARE PRODUCTS MARKET, BY REGION,
2018–2025 (USD MILLION) 147

10.4 ASIA PACIFIC 159
10.4.1 ASIA PACIFIC: ANTI-MONEY LAUNDERING SOLUTION MARKET DRIVERS 159
10.4.2 ASIA PACIFIC: COVID-19 IMPACT 160
10.4.3 ASIA PACIFIC: REGULATIONS 160
FIGURE 31 ASIA PACIFIC: MARKET SNAPSHOT 161
10.4.4 MARKET ESTIMATES AND FORECASTS, BY COMPONENT, 2014–2025 161
TABLE 161 ASIA PACIFIC: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2014–2019 (USD MILLION) 161
TABLE 162 ASIA PACIFIC: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2019–2025 (USD MILLION) 162
10.4.5 MARKET ESTIMATES AND FORECASTS, BY SOLUTION, 2014–2025 162
TABLE 163 ASIA PACIFIC: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2014–2019 (USD MILLION) 162
TABLE 164 ASIA PACIFIC: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2019–2025 (USD MILLION) 162
10.4.6 MARKET ESTIMATES AND FORECASTS, BY SERVICE, 2014–2025 163
TABLE 165 ASIA PACIFIC: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2014–2019 (USD MILLION) 163
TABLE 166 ASIA PACIFIC: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2019–2025 (USD MILLION) 163
10.4.7 MARKET ESTIMATES AND FORECASTS, BY DEPLOYMENT MODE, 2014–2025 163
TABLE 167 ASIA PACIFIC: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2014–2019 (USD MILLION) 163
TABLE 168 ASIA PACIFIC: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2019–2025 (USD MILLION) 164
10.4.8 MARKET ESTIMATES AND FORECASTS, BY ORGANIZATION SIZE, 2014–2025 164
TABLE 169 ASIA PACIFIC: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2014–2019 (USD MILLION) 164
TABLE 170 ASIA PACIFIC: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2019–2025 (USD MILLION) 164
10.4.9 MARKET ESTIMATES AND FORECASTS, BY END USER, 2014–2025 165
TABLE 171 ASIA PACIFIC: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2014–2019 (USD MILLION) 165
TABLE 172 ASIA PACIFIC: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2019–2025 (USD MILLION) 165
10.4.10 MARKET ESTIMATES AND FORECASTS, BY COUNTRY, 2014–2025 165
TABLE 173 ASIA PACIFIC: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COUNTRY, 2014–2019 (USD MILLION) 165
TABLE 174 ASIA PACIFIC: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COUNTRY, 2019–2025 (USD MILLION) 166
10.4.11 JAPAN 166
10.4.11.1 Market estimates and forecasts, by component, 2014–2025 167
TABLE 175 JAPAN: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2014–2019 (USD MILLION) 167
TABLE 176 JAPAN: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2019–2025 (USD MILLION) 167
10.4.11.2 Market estimates and forecasts, by solution, 2014–2025 167
TABLE 177 JAPAN: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2014–2019 (USD MILLION) 167
TABLE 178 JAPAN: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2019–2025 (USD MILLION) 168
10.4.11.3 Market estimates and forecasts, by service, 2014–2025 168
TABLE 179 JAPAN: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2014–2019 (USD MILLION) 168
TABLE 180 JAPAN: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2019–2025 (USD MILLION) 168
10.4.11.4 Market estimates and forecasts, by deployment mode, 2014–2025 169
TABLE 181 JAPAN: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2014–2019 (USD MILLION) 169
TABLE 182 JAPAN: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2019–2025 (USD MILLION) 169
10.4.11.5 Market estimates and forecasts, by organization size, 2014–2025 169
TABLE 183 JAPAN: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2014–2019 (USD MILLION) 169
TABLE 184 JAPAN: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2019–2025 (USD MILLION) 170
10.4.11.6 Market estimates and forecasts, by end user, 2014–2025 170
TABLE 185 JAPAN: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2014–2019 (USD MILLION) 170
TABLE 186 JAPAN: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2019–2025 (USD MILLION) 170
10.4.12 AUSTRALIA AND NEW ZEALAND 171
10.4.12.1 Market estimates and forecasts, by component, 2014–2025 171
TABLE 187 AUSTRALIA AND NEW ZEALAND: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2014–2019 (USD MILLION) 171
TABLE 188 AUSTRALIA AND NEW ZEALAND: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2019–2025 (USD MILLION) 171
10.4.12.2 Market estimates and forecasts, by solution, 2014–2025 172
TABLE 189 AUSTRALIA AND NEW ZEALAND: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2014–2019 (USD MILLION) 172
TABLE 190 AUSTRALIA AND NEW ZEALAND: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2019–2025 (USD MILLION) 172
10.4.12.3 Market estimates and forecasts, by service, 2014–2025 172
TABLE 191 AUSTRALIA AND NEW ZEALAND: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2014–2019 (USD MILLION) 172
TABLE 192 AUSTRALIA AND NEW ZEALAND: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2019–2025 (USD MILLION) 173
10.4.12.4 Market estimates and forecasts, by deployment mode, 2014–2025 173
TABLE 193 AUSTRALIA AND NEW ZEALAND: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2014–2019 (USD MILLION) 173
TABLE 194 AUSTRALIA AND NEW ZEALAND: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2019–2025 (USD MILLION) 173
10.4.12.5 Market estimates and forecasts, by organization size, 2014–2025 174
TABLE 195 AUSTRALIA AND NEW ZEALAND: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2014–2019 (USD MILLION) 174
TABLE 196 AUSTRALIA AND NEW ZEALAND: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2019–2025 (USD MILLION) 174
10.4.12.6 Market estimates and forecasts, by end user, 2014–2025 174
TABLE 197 AUSTRALIA AND NEW ZEALAND: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2014–2019 (USD MILLION) 174
TABLE 198 AUSTRALIA AND NEW ZEALAND: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2019–2025 (USD MILLION) 175

10.4.13 SINGAPORE 175
10.4.13.1 Market estimates and forecasts, by component, 2014–2025 175
TABLE 199 SINGAPORE: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2014–2019 (USD MILLION) 175
TABLE 200 SINGAPORE: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2019–2025 (USD MILLION) 176
10.4.13.2 Market estimates and forecasts, by solution, 2014–2025 176
TABLE 201 SINGAPORE: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2014–2019 (USD MILLION) 176
TABLE 202 SINGAPORE: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2019–2025 (USD MILLION) 176
10.4.13.3 Market estimates and forecasts, by service, 2014–2025 177
TABLE 203 SINGAPORE: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2014–2019 (USD MILLION) 177
TABLE 204 SINGAPORE: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2019–2025 (USD MILLION) 177
10.4.13.4 Market estimates and forecasts, by deployment mode, 2014–2025 177
TABLE 205 SINGAPORE: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2014–2019 (USD MILLION) 177
TABLE 206 SINGAPORE: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2019–2025 (USD MILLION) 178
10.4.13.5 Market estimates and forecasts, by organization size, 2014–2025 178
TABLE 207 SINGAPORE: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2014–2019 (USD MILLION) 178
TABLE 208 SINGAPORE: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2019–2025 (USD MILLION) 178
10.4.13.6 Market estimates and forecasts, by end user, 2014–2025 179
TABLE 209 SINGAPORE: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2014–2019 (USD MILLION) 179
TABLE 210 SINGAPORE: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2019–2025 (USD MILLION) 179
10.4.14 INDIA 179
10.4.14.1 Market estimates and forecasts, by component, 2014–2025 180
TABLE 211 INDIA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2014–2019 (USD MILLION) 180
TABLE 212 INDIA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2019–2025 (USD MILLION) 180
10.4.14.2 Market estimates and forecasts, by solution, 2014–2025 180
TABLE 213 INDIA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2014–2019 (USD MILLION) 180
TABLE 214 INDIA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2019–2025 (USD MILLION) 181
10.4.14.3 Market estimates and forecasts, by service, 2014–2025 181
TABLE 215 INDIA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2014–2019 (USD MILLION) 181
TABLE 216 INDIA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2019–2025 (USD MILLION) 181
10.4.14.4 Market estimates and forecasts, by deployment mode, 2014–2025 182
TABLE 217 INDIA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2014–2019 (USD MILLION) 182
TABLE 218 INDIA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2019–2025 (USD MILLION) 182
10.4.14.5 Market estimates and forecasts, by organization size, 2014–2025 182
TABLE 219 INDIA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2014–2019 (USD MILLION) 182
TABLE 220 INDIA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2019–2025 (USD MILLION) 183
10.4.14.6 Market estimates and forecasts, by end user, 2014–2025 183
TABLE 221 INDIA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2014–2019 (USD MILLION) 183
TABLE 222 INDIA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2019–2025 (USD MILLION) 183
10.4.15 REST OF ASIA PACIFIC 184
10.4.15.1 Market estimates and forecasts, by component, 2014–2025 184
TABLE 223 REST OF ASIA PACIFIC: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2014–2019 (USD MILLION) 184
TABLE 224 REST OF ASIA PACIFIC: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2019–2025 (USD MILLION) 184
10.4.15.2 Market estimates and forecasts, by solution, 2014–2025 185
TABLE 225 REST OF ASIA PACIFIC: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2014–2019 (USD MILLION) 185
TABLE 226 REST OF ASIA PACIFIC: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2019–2025 (USD MILLION) 185
10.4.15.3 Market estimates and forecasts, by service, 2014–2025 185
TABLE 227 REST OF ASIA PACIFIC: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2014–2019 (USD MILLION) 185
TABLE 228 REST OF ASIA PACIFIC: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2019–2025 (USD MILLION) 186
10.4.15.4 Market estimates and forecasts, by deployment mode, 2014–2025 186
TABLE 229 REST OF ASIA PACIFIC: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2014–2019 (USD MILLION) 186
TABLE 230 REST OF ASIA PACIFIC: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2019–2025 (USD MILLION) 186
10.4.15.5 Market estimates and forecasts, by organization size, 2014–2025 187
TABLE 231 REST OF ASIA PACIFIC: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2014–2019 (USD MILLION) 187
TABLE 232 REST OF ASIA PACIFIC: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE,
2019–2025 (USD MILLION) 187
10.4.15.6 Market estimates and forecasts, by end user, 2014–2025 187
TABLE 233 REST OF ASIA PACIFIC: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2014–2019 (USD MILLION) 187
TABLE 234 REST OF ASIA PACIFIC: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2019–2025 (USD MILLION) 188
10.5 MIDDLE EAST AND AFRICA 188
10.5.1 MIDDLE EAST AND AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET DRIVERS 188
10.5.2 MIDDLE EAST AND AFRICA: COVID-19 IMPACT 189
10.5.3 MIDDLE EAST AND AFRICA: REGULATIONS 189
10.5.4 MARKET ESTIMATES AND FORECASTS BY COMPONENT, 2014-2025 189
TABLE 235 MIDDLE EAST AND AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2014–2019 (USD MILLION) 189
TABLE 236 MIDDLE EAST AND AFRICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2019–2025 (USD MILLION) 190
10.5.5 MARKET ESTIMATES AND FORECASTS BY SOLUTION, 2014-2025 190
TABLE 237 MIDDLE EAST AND AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2014–2019 (USD MILLION) 190
TABLE 238 MIDDLE EAST AND AFRICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2019–2025 (USD MILLION) 190
10.5.6 MARKET ESTIMATES AND FORECASTS BY SERVICE, 2014-2025 191
TABLE 239 MIDDLE EAST AND AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2014–2019 (USD MILLION) 191
TABLE 240 MIDDLE EAST AND AFRICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2019–2025 (USD MILLION) 191
10.5.7 MARKET ESTIMATES AND FORECASTS BY DEPLOYMENT MODE, 2014-2025 191
TABLE 241 MIDDLE EAST AND AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2014–2019 (USD MILLION) 191
TABLE 242 MIDDLE EAST AND AFRICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2019–2025 (USD MILLION) 192
10.5.8 MARKET ESTIMATES AND FORECASTS BY ORGANIZATION SIZE, 2014-2025 192
TABLE 243 MIDDLE EAST AND AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2014–2019 (USD MILLION) 192
TABLE 244 MIDDLE EAST AND AFRICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2019–2025 (USD MILLION) 192
10.5.9 MARKET ESTIMATES AND FORECASTS BY END USER, 2014-2025 193
TABLE 245 MIDDLE EAST AND AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2014–2019 (USD MILLION) 193
TABLE 246 MIDDLE EAST AND AFRICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2019–2025 (USD MILLION) 193
10.5.10 MARKET ESTIMATES AND FORECASTS BY COUNTRY, 2014-2025 193
TABLE 247 MIDDLE EAST AND AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COUNTRY, 2014–2019 (USD MILLION) 193
TABLE 248 MIDDLE EAST AND AFRICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COUNTRY, 2019–2025 (USD MILLION) 194

10.5.11 UNITED ARAB EMIRATES 194
10.5.11.1 Market estimates and forecasts by component, 2014-2025 195
TABLE 249 UNITED ARAB EMIRATES: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2014–2019 (USD MILLION) 195
TABLE 250 UNITED ARAB EMIRATES: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2019–2025 (USD MILLION) 195
10.5.11.2 Market estimates and forecasts by solution, 2014-2025 195
TABLE 251 UNITED ARAB EMIRATES: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2014–2019 (USD MILLION) 195
TABLE 252 UNITED ARAB EMIRATES: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2019–2025 (USD MILLION) 196
10.5.11.3 Market estimates and forecasts by service, 2014-2025 196
TABLE 253 UNITED ARAB EMIRATES: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2014–2019 (USD MILLION) 196
TABLE 254 UNITED ARAB EMIRATES: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2019–2025 (USD MILLION) 196
10.5.11.4 Market estimates and forecasts by deployment mode, 2014-2025 197
TABLE 255 UNITED ARAB EMIRATES: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2014–2019 (USD MILLION) 197
TABLE 256 UNITED ARAB EMIRATES: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2019–2025 (USD MILLION) 197
10.5.11.5 Market estimates and forecasts by organization size, 2014-2025 197
TABLE 257 UNITED ARAB EMIRATES: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2014–2019 (USD MILLION) 197
TABLE 258 UNITED ARAB EMIRATES: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2019–2025 (USD MILLION) 198
10.5.11.6 Market estimates and forecasts by end user, 2014-2025 198
TABLE 259 UNITED ARAB EMIRATES: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2014–2019 (USD MILLION) 198
TABLE 260 UNITED ARAB EMIRATES: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2019–2025 (USD MILLION) 198
10.5.12 KINGDOM OF SAUDI ARABIA 199
10.5.12.1 Market estimates and forecasts by component, 2014-2025 199
TABLE 261 KINGDOM OF SAUDI ARABIA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2014–2019 (USD MILLION) 199
TABLE 262 KINGDOM OF SAUDI ARABIA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2019–2025 (USD MILLION) 199
10.5.12.2 Market estimates and forecasts by solution, 2014-2025 200
TABLE 263 KINGDOM OF SAUDI ARABIA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2014–2019 (USD MILLION) 200
TABLE 264 KINGDOM OF SAUDI ARABIA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2019–2025 (USD MILLION) 200
10.5.12.3 Market estimates and forecasts by service, 2014-2025 200
TABLE 265 KINGDOM OF SAUDI ARABIA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2014–2019 (USD MILLION) 200
TABLE 266 KINGDOM OF SAUDI ARABIA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2019–2025 (USD MILLION) 201
10.5.12.4 Market estimates and forecasts by deployment mode, 2014-2025 201
TABLE 267 KINGDOM OF SAUDI ARABIA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2014–2019 (USD MILLION) 201
TABLE 268 KINGDOM OF SAUDI ARABIA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2019–2025 (USD MILLION) 201
10.5.12.5 Market estimates and forecasts by organization size, 2014-2025 202
TABLE 269 KINGDOM OF SAUDI ARABIA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2014–2019 (USD MILLION) 202
TABLE 270 KINGDOM OF SAUDI ARABIA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2019–2025 (USD MILLION) 202
10.5.12.6 Market estimates and forecasts by end user, 2014-2025 202
TABLE 271 KINGDOM OF SAUDI ARABIA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2014–2019 (USD MILLION) 202
TABLE 272 KINGDOM OF SAUDI ARABIA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2019–2025 (USD MILLION) 203
10.5.13 SOUTH AFRICA 203
10.5.13.1 Market estimates and forecasts by component, 2014-2025 203
TABLE 273 SOUTH AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2014–2019 (USD MILLION) 203
TABLE 274 SOUTH AFRICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2019–2025 (USD MILLION) 204
10.5.13.2 Market estimates and forecasts by solution, 2014-2025 204
TABLE 275 SOUTH AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2014–2019 (USD MILLION) 204
TABLE 276 SOUTH AFRICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2019–2025 (USD MILLION) 204
10.5.13.3 Market estimates and forecasts by service, 2014-2025 205
TABLE 277 SOUTH AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2014–2019 (USD MILLION) 205
TABLE 278 SOUTH AFRICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2019–2025 (USD MILLION) 205
10.5.13.4 Market estimates and forecasts by deployment mode, 2014-2025 205
TABLE 279 SOUTH AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2014–2019 (USD MILLION) 205
TABLE 280 SOUTH AFRICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2019–2025 (USD MILLION) 206
10.5.13.5 Market estimates and forecasts by organization size, 2014-2025 206
TABLE 281 SOUTH AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2014–2019 (USD MILLION) 206
TABLE 282 SOUTH AFRICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2019–2025 (USD MILLION) 206
10.5.13.6 Market estimates and forecasts by end user, 2014-2025 207
TABLE 283 SOUTH AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2014–2019 (USD MILLION) 207
TABLE 284 SOUTH AFRICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2019–2025 (USD MILLION) 207
10.5.14 REST OF MIDDLE EAST AND AFRICA 207
10.5.14.1 Market estimates and forecasts by component, 2014-2025 208
TABLE 285 REST OF MIDDLE EAST AND AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2014–2019 (USD MILLION) 208
TABLE 286 REST OF MIDDLE EAST AND AFRICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2019–2025 (USD MILLION) 208
10.5.14.2 Market estimates and forecasts by solution, 2014-2025 208
TABLE 287 REST OF MIDDLE EAST AND AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2014–2019 (USD MILLION) 208
TABLE 288 REST OF MIDDLE EAST AND AFRICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2019–2025 (USD MILLION) 209
10.5.14.3 Market estimates and forecasts by service, 2014-2025 209
TABLE 289 REST OF MIDDLE EAST AND AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2014–2019 (USD MILLION) 209
TABLE 290 REST OF MIDDLE EAST AND AFRICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2019–2025
(USD MILLION) 209
10.5.14.4 Market estimates and forecasts by deployment mode, 2014-2025 210
TABLE 291 REST OF MIDDLE EAST AND AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2014–2019 (USD MILLION) 210
TABLE 292 REST OF MIDDLE EAST AND AFRICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE,
2019–2025 (USD MILLION) 210
10.5.14.5 Market estimates and forecasts by organization size, 2014-2025 210
TABLE 293 REST OF MIDDLE EAST AND AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2014–2019 (USD MILLION) 210
TABLE 294 REST OF MIDDLE EAST AND AFRICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2019–2025 (USD MILLION) 211
10.5.14.6 Market estimates and forecasts by end user, 2014-2025 211
TABLE 295 REST OF MIDDLE EAST AND AFRICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2014–2019 (USD MILLION) 211
TABLE 296 REST OF MIDDLE EAST AND AFRICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER,
2019–2025 (USD MILLION) 211
10.6 LATIN AMERICA 212
10.6.1 LATIN AMERICA: ANTI-MONEY LAUNDERING SOLUTION MARKET DRIVERS 212
10.6.2 LATIN AMERICA: COVID-19 IMPACT 212
10.6.3 LATIN AMERICA: AML REGULATIONS 213
10.6.3.1 Market estimates and forecasts by component, 2014-2025 213
TABLE 297 LATIN AMERICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2014–2019 (USD MILLION) 213
TABLE 298 LATIN AMERICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2019–2025 (USD MILLION) 213
10.6.3.2 Market estimates and forecasts by solution, 2014-2025 214
TABLE 299 LATIN AMERICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE,
BY SOLUTION, 2014–2019 (USD MILLION) 214
TABLE 300 LATIN AMERICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2019–2025 (USD MILLION) 214
10.6.3.3 Market estimates and forecasts by service, 2014-2025 214
TABLE 301 LATIN AMERICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2014–2019 (USD MILLION) 214
TABLE 302 LATIN AMERICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2019–2025 (USD MILLION) 215
10.6.3.4 Market estimates and forecasts by deployment mode, 2014-2025 215
TABLE 303 LATIN AMERICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2014–2019 (USD MILLION) 215
TABLE 304 LATIN AMERICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2019–2025 (USD MILLION) 215
10.6.3.5 Market estimates and forecasts by organization size, 2014-2025 216
TABLE 305 LATIN AMERICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2014–2019 (USD MILLION) 216
TABLE 306 LATIN AMERICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2019–2025 (USD MILLION) 216
10.6.3.6 Market estimates and forecasts by end user, 2014-2025 216
TABLE 307 LATIN AMERICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2014–2019 (USD MILLION) 216
TABLE 308 LATIN AMERICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2019–2025 (USD MILLION) 217
10.6.3.7 Market estimates and forecasts by country, 2014-2025 217
TABLE 309 LATIN AMERICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COUNTRY, 2014–2019 (USD MILLION) 217
TABLE 310 LATIN AMERICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COUNTRY, 2019–2025 (USD MILLION) 217
10.6.4 MEXICO 218
10.6.4.1 Market estimates and forecasts by component, 2014-2025 218
TABLE 311 MEXICO: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2014–2019 (USD MILLION) 218
TABLE 312 MEXICO: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2019–2025 (USD MILLION) 218
10.6.4.2 Market estimates and forecasts by solution, 2014-2025 219
TABLE 313 MEXICO: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2014–2019 (USD MILLION) 219
TABLE 314 MEXICO: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2019–2025 (USD MILLION) 219
10.6.4.3 Market estimates and forecasts by service, 2014-2025 219
TABLE 315 MEXICO: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2014–2019 (USD MILLION) 219
TABLE 316 MEXICO: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2019–2025 (USD MILLION) 220
10.6.4.4 Market estimates and forecasts by deployment mode, 2014-2025 220
TABLE 317 MEXICO: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2014–2019 (USD MILLION) 220
TABLE 318 MEXICO: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2019–2025 (USD MILLION) 220

10.6.4.5 Market estimates and forecasts by organization size, 2014-2025 221
TABLE 319 MEXICO: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2014–2019 (USD MILLION) 221
TABLE 320 MEXICO: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2019–2025 (USD MILLION) 221
10.6.4.6 Market estimates and forecasts by end user, 2014-2025 221
TABLE 321 MEXICO: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2014–2019 (USD MILLION) 221
TABLE 322 MEXICO: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2019–2025 (USD MILLION) 222
10.6.5 BRAZIL 222
10.6.5.1 Market estimates and forecasts by component, 2014-2025 222
TABLE 323 BRAZIL: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2014–2019 (USD MILLION) 222
TABLE 324 BRAZIL: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2019–2025 (USD MILLION) 223
10.6.5.2 Market estimates and forecast by solution, 2014-2025 223
TABLE 325 BRAZIL: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2014–2019 (USD MILLION) 223
TABLE 326 BRAZIL: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2019–2025 (USD MILLION) 223
10.6.5.3 Market estimates and forecasts by service, 2014-2025 224
TABLE 327 BRAZIL: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2014–2019 (USD MILLION) 224
TABLE 328 BRAZIL: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2019–2025 (USD MILLION) 224
10.6.5.4 Market estimates and forecast by deployment mode, 2014-2025 224
TABLE 329 BRAZIL: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2014–2019 (USD MILLION) 224
TABLE 330 BRAZIL: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2019–2025 (USD MILLION) 225
10.6.5.5 Market estimates and forecasts by organization size, 2014-2025 225
TABLE 331 BRAZIL: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2014–2019 (USD MILLION) 225
TABLE 332 BRAZIL: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2019–2025 (USD MILLION) 225
10.6.5.6 Market estimates and forecast by end user, 2014-2025 226
TABLE 333 BRAZIL: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2014–2019 (USD MILLION) 226
TABLE 334 BRAZIL: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2019–2025 (USD MILLION) 226
10.6.6 REST OF LATIN AMERICA 226
10.6.6.1 Market estimates and forecasts by component, 2014-2025 227
TABLE 335 REST OF LATIN AMERICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2014–2019 (USD MILLION) 227
TABLE 336 REST OF LATIN AMERICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY COMPONENT, 2019–2025 (USD MILLION) 227
10.6.6.2 Market estimates and forecasts by solution, 2014-2025 227
TABLE 337 REST OF LATIN AMERICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2014–2019 (USD MILLION) 227
TABLE 338 REST OF LATIN AMERICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SOLUTION, 2019–2025 (USD MILLION) 228
10.6.6.3 Market estimates and forecasts by service, 2014-2025 228
TABLE 339 REST OF LATIN AMERICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2014–2019 (USD MILLION) 228
TABLE 340 REST OF LATIN AMERICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY SERVICE, 2019–2025 (USD MILLION) 228
10.6.6.4 Market estimates and forecasts by deployment mode, 2014-2025 229
TABLE 341 REST OF LATIN AMERICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2014–2019 (USD MILLION) 229
TABLE 342 REST OF LATIN AMERICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2019–2025 (USD MILLION) 229
10.6.6.5 Market estimates and forecasts by organization size, 2014-2025 229
TABLE 343 REST OF LATIN AMERICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2014–2019 (USD MILLION) 229
TABLE 344 REST OF LATIN AMERICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE,
2019–2025 (USD MILLION) 230
10.6.6.6 Market estimates and forecasts by end user, 2014-2025 230
TABLE 345 REST OF LATIN AMERICA: ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2014–2019 (USD MILLION) 230
TABLE 346 REST OF LATIN AMERICA: POST-COVID-19 ANTI-MONEY LAUNDERING SOLUTION MARKET SIZE, BY END USER, 2019–2025 (USD MILLION) 230
11 COMPETITIVE LANDSCAPE 231
11.1 OVERVIEW 231
11.2 MARKET EVALUATION FRAMEWORK 231
FIGURE 32 MARKET EVALUATION FRAMEWORK: ANTI MONEY LAUNDERING MARKET WITNESSED EXPANSIONS AND CONSOLIDATIONS BETWEEN 2019 AND 2020 231
11.3 KEY PLAYERS RANKING 232
FIGURE 33 RANKING OF KEY PLAYERS IN ANTI-MONEY LAUNDERING SOLUTIONS MARKET, 2019 232
11.4 REVENUE ANALYSIS OF TOP FIVE MARKET PLAYERS 232
FIGURE 34 TOP FIVE PLAYERS DOMINATED MARKET IN LAST THREE YEARS 232
12 COMPANY EVALUATION MATRIX AND COMPANY PROFILES 234
12.1 OVERVIEW 234
12.2 COMPANY EVALUATION MATRIX 234
12.2.1 STAR 234
12.2.2 EMERGING LEADERS 234
12.2.3 PERVASIVE 234
FIGURE 35 ANTI-MONEY LAUNDERING SOLUTION MARKET (GLOBAL),
COMPANY EVALUATION MATRIX, 2020 235
12.3 COMPANY PROFILES 236
(Business Overview, Solutions, Products & Services, Key Insights, Recent Developments, SWOT Analysis, MnM View)*
12.3.1 ACI WORLDWIDE 236
FIGURE 36 ACI WORLDWIDE: COMPANY SNAPSHOT 236
FIGURE 37 ACI WORLDWIDE: SWOT ANALYSIS 239
12.3.2 BAE SYSTEMS 240
FIGURE 38 BAE SYSTEMS: COMPANY SNAPSHOT 240
FIGURE 39 BAE SYSTEMS: SWOT ANALYSIS 244
12.3.3 NICE ACTIMIZE 246
FIGURE 40 NICE ACTIMIZE: COMPANY SNAPSHOT 246
FIGURE 41 NICE ACTIMIZE: SWOT ANALYSIS 250
12.3.4 FICO 252
FIGURE 42 FICO: COMPANY SNAPSHOT 252
FIGURE 43 FICO: SWOT ANALYSIS 255
12.3.5 SAS INSTITUTE 257
FIGURE 44 SAS INSTITUTE: COMPANY SNAPSHOT 257
FIGURE 45 SAS INSTITUTE: SWOT ANALYSIS 260
12.3.6 ORACLE 261
FIGURE 46 ORACLE: COMPANY SNAPSHOT 261
12.3.7 EXPERIAN 264
FIGURE 47 EXPERIAN: COMPANY SNAPSHOT 264
12.3.8 LEXISNEXIS RISK SOLUTIONS 267
12.3.9 FISERV 270
FIGURE 48 FISERV: COMPANY SNAPSHOT 270
12.3.10 FIS 273
FIGURE 49 FIS: COMPANY SNAPSHOT 273
12.3.11 DIXTIOR 276
12.3.12 TRANSUNION 279
12.3.13 WOLTERS KLUWER 280
12.3.14 TEMENOS 281
12.3.15 NELITO SYSTEMS 282
12.3.16 TCS 283
12.3.17 WORKFUSION 284
*Details on Business Overview, Solution, Products & Services, Key Insights, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12.4 SMES/ STARTUPS COMPANY EVALUATION MATRIX 285
12.4.1 PROGRESSIVE COMPANIES 285
12.4.2 RESPONSIVE COMPANIES 285
12.4.3 DYNAMIC COMPANIES 285
12.4.4 STARTING BLOCKS 285
FIGURE 50 ANTI MONEY LAUNDERING MARKET (GLOBAL), COMPANY EVALUATION MATRIX, FOR STARTUPS, 2020 286

12.5 STARTUP PROFILES 287
12.5.1 NAPIER 287
12.5.2 QUANTAVERSE 288
12.5.3 COMPLY ADVANTAGE 289
12.6 OTHER MAJOR GLOBAL AND REGIONAL AML SOLUTION MARKET VENDORS 290
12.7 RIGHT TO WIN 291
13 ADJACENT MARKETS 293
13.1 INTRODUCTION TO ADJACENT MARKETS 293
TABLE 347 ADJACENT MARKETS AND FORECASTS 293
13.1.1 LIMITATIONS 293
13.2 ENTERPRISE GOVERNANCE, RISK AND COMPLIANCE MARKET 294
13.2.1 ADJACENT MARKET: EGRC MARKET, BY SOFTWARE TYPE 294
TABLE 348 SOFTWARE: ENTERPRISE GOVERNANCE, RISK, AND COMPLIANCE MARKET SIZE, BY TYPE, 2014–2019 (USD MILLION) 294
TABLE 349 POST-COVID-19: ENTERPRISE GOVERNANCE, RISK, AND COMPLIANCE MARKET SIZE, BY SOFTWARE TYPE, 2019–2025 (USD MILLION) 294
13.2.2 ADJACENT MARKET: EGRC MARKET, BY REGION 295
TABLE 350 NORTH AMERICA: ENTERPRISE GOVERNANCE, RISK, AND COMPLIANCE MARKET SIZE, BY SOFTWARE TYPE, 2014–2019 (USD MILLION) 295
TABLE 351 POST-COVID-19: NORTH AMERICA ENTERPRISE GOVERNANCE, RISK, AND COMPLIANCE MARKET SIZE, BY SOFTWARE TYPE, 2019–2025
(USD MILLION) 295
TABLE 352 EUROPE: ENTERPRISE GOVERNANCE, RISK, AND COMPLIANCE MARKET SIZE, BY SOFTWARE TYPE, 2014–2019 (USD MILLION) 296
TABLE 353 POST-COVID-19: EUROPE ENTERPRISE GOVERNANCE, RISK, AND COMPLIANCE MARKET SIZE, BY SOFTWARE TYPE,
2019–2025 (USD MILLION) 296
TABLE 354 ASIA PACIFIC: ENTERPRISE GOVERNANCE, RISK, AND COMPLIANCE MARKET SIZE, BY SOFTWARE TYPE, 2014–2019 (USD MILLION) 297
TABLE 355 POST-COVID-19: ASIA PACIFIC ENTERPRISE GOVERNANCE, RISK, AND COMPLIANCE MARKET SIZE, BY SOFTWARE TYPE, 2019–2025
(USD MILLION) 297
TABLE 356 MIDDLE EAST AND AFRICA: ENTERPRISE GOVERNANCE, RISK, AND COMPLIANCE MARKET SIZE, BY SOFTWARE TYPE, 2014–2019
(USD MILLION) 298
TABLE 357 POST-COVID-19: MIDDLE EAST AND AFRICA ENTERPRISE GOVERNANCE, RISK, AND COMPLIANCE MARKET SIZE, BY SOFTWARE TYPE, 2019–2025 (USD MILLION) 298
TABLE 358 LATIN AMERICA: ENTERPRISE GOVERNANCE, RISK, AND COMPLIANCE MARKET SIZE, BY SOFTWARE TYPE, 2014–2019 (USD MILLION) 299
TABLE 359 POST-COVID-19: LATIN AMERICA ENTERPRISE GOVERNANCE, RISK, AND COMPLIANCE MARKET SIZE, BY SOFTWARE TYPE, 2019–2025
(USD MILLION) 299
13.3 FRAUD DETECTION AND PREVENTION MARKET 300
13.3.1 ADJACENT MARKET: FDP MARKET, BY COMPONENT 300
TABLE 360 FRAUD DETECTION AND PREVENTION MARKET SIZE, BY COMPONENT,
2016–2023 (USD BILLION) 300
13.3.2 ADJACENT MARKET: FDP MARKET, BY SOLUTION 300
TABLE 361 FRAUD DETECTION AND PREVENTION MARKET SIZE, BY SOLUTION,
2016–2023 (USD BILLION) 300
TABLE 362 FRAUD ANALYTICS: FRAUD DETECTION AND PREVENTION MARKET SIZE,
BY REGION, 2016–2023 (USD BILLION) 300
13.3.3 ADJACENT MARKET: FDP MARKET, BY SERVICE 301
TABLE 363 FRAUD DETECTION AND PREVENTION MARKET SIZE, BY SERVICE,
2016–2023 (USD BILLION) 301
13.3.4 ADJACENT MARKET: FDP MARKET, BY APPLICATION AREA 301
TABLE 364 FRAUD DETECTION AND PREVENTION MARKET SIZE, BY APPLICATION AREA, 2016–2023 (USD BILLION) 301
TABLE 365 IDENTITY THEFT: FRAUD DETECTION AND PREVENTION MARKET SIZE,
BY REGION, 2016–2023 (USD BILLION) 301
TABLE 366 PAYMENT FRAUD: FRAUD DETECTION AND PREVENTION MARKET SIZE,
BY TYPE, 2016–2023 (USD BILLION) 302
TABLE 367 PAYMENT FRAUD: FRAUD DETECTION AND PREVENTION MARKET SIZE,
BY REGION, 2016–2023 (USD BILLION) 302
TABLE 368 MONEY LAUNDERING: FRAUD DETECTION AND PREVENTION MARKET SIZE, BY REGION, 2016–2023 (USD BILLION) 302
13.3.5 ADJACENT MARKET: FDP MARKET, BY BFSI VERTICAL 303
TABLE 369 BANKING, FINANCIAL SERVICES, AND INSURANCE: FRAUD DETECTION AND PREVENTION MARKET SIZE, BY REGION, 2016–2023 (USD BILLION) 303
13.3.6 ADJACENT MARKET: FDP MARKET, BY REGION 303
TABLE 370 NORTH AMERICA: FRAUD DETECTION AND PREVENTION MARKET SIZE,
BY APPLICATION AREA, 2016–2023 (USD BILLION) 303
TABLE 371 EUROPE: FRAUD DETECTION AND PREVENTION MARKET SIZE,
BY APPLICATION AREA, 2016–2023 (USD BILLION) 303
TABLE 372 ASIA PACIFIC: FRAUD DETECTION AND PREVENTION MARKET SIZE,
BY APPLICATION AREA, 2016–2023 (USD BILLION) 304
TABLE 373 MIDDLE EAST AND AFRICA: FRAUD DETECTION AND PREVENTION MARKET SIZE, BY APPLICATION AREA, 2016–2023 (USD BILLION) 304
TABLE 374 LATIN AMERICA: FRAUD DETECTION AND PREVENTION MARKET SIZE,
BY APPLICATION AREA, 2016–2023 (USD BILLION) 304
13.4 TRANSACTION MONITORING MARKET 305
13.4.1 ADJACENT MARKET: TRANSACTION MONITORING MARKET, BY COMPONENT 305
TABLE 375 TRANSACTION MONITORING MARKET SIZE, BY COMPONENT,
2016–2023 (USD BILLION) 305
13.4.2 ADJACENT MARKET: TRANSACTION MONITORING MARKET, BY APPLICATION AREA 305
TABLE 376 TRANSACTION MONITORING MARKET SIZE, BY SOLUTION,
2016–2023 (USD MILLION) 305
13.4.3 ADJACENT MARKET: TRANSACTION MONITORING MARKET, BY BFSI VERTICAL 305
TABLE 377 BANKING, FINANCIAL SERVICES, AND INSURANCE: TRANSACTION MONITORING MARKET SIZE, BY REGION, 2016–2023 (USD MILLION) 305
13.4.4 ADJACENT MARKET: TRANSACTION MONITORING MARKET, BY REGION 306
TABLE 378 TRANSACTION MONITORING MARKET SIZE, BY REGION,
2016–2023 (USD MILLION) 306
TABLE 379 NORTH AMERICA: TRANSACTION MONITORING MARKET SIZE,
BY APPLICATION AREA, 2016–2023 (USD MILLION) 306
TABLE 380 EUROPE: TRANSACTION MONITORING MARKET SIZE, BY APPLICATION AREA, 2016–2023 (USD MILLION) 306
TABLE 381 ASIA PACIFIC: TRANSACTION MONITORING MARKET SIZE, BY APPLICATION AREA, 2016–2023 (USD MILLION) 307
TABLE 382 MIDDLE EAST AND AFRICA: TRANSACTION MONITORING MARKET SIZE,
BY APPLICATION AREA, 2016–2023 (USD MILLION) 307
TABLE 383 LATIN AMERICA: TRANSACTION MONITORING MARKET SIZE, BY APPLICATION AREA, 2016–2023 (USD MILLION) 307
14 APPENDIX 308
14.1 DISCUSSION GUIDE 308
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 313
14.3 AVAILABLE CUSTOMIZATIONS 315
14.4 RELATED REPORTS 315
14.5 AUTHOR DETAILS 316

★調査レポート[マウスモデルの世界市場予測(〜2025):種類別(近交系、ノックアウト)、技術別(CRISPR、TALEN、ZFN)、用途別(腫瘍学、糖尿病、免疫学)、サービス別(育種、凍結保存、遺伝子検査)、ケア製品別(ケージ、寝具、飼料)、地域別] ( Mice Model Market by Mice Type (Inbred, Knockout), Technology (CRISPR, TALEN, ZFN), Application (Oncology, Diabetes, Immunology), Service (Breeding, Cryopreservation, Genetic testing), Care Products (Cages, Bedding, Feed), Region - Global Forecast to 2025 / BT 2192) 販売に関する免責事項
[マウスモデルの世界市場予測(〜2025):種類別(近交系、ノックアウト)、技術別(CRISPR、TALEN、ZFN)、用途別(腫瘍学、糖尿病、免疫学)、サービス別(育種、凍結保存、遺伝子検査)、ケア製品別(ケージ、寝具、飼料)、地域別] ( Mice Model Market by Mice Type (Inbred, Knockout), Technology (CRISPR, TALEN, ZFN), Application (Oncology, Diabetes, Immunology), Service (Breeding, Cryopreservation, Genetic testing), Care Products (Cages, Bedding, Feed), Region - Global Forecast to 2025 / BT 2192) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆